| Teva Pharma AG - Bosutinib-Teva 400 mg, Filmtabletten | | 69223 | | 02 | | Bosutinib-Teva 400 mg | | Filmtabletten | | L01EA04 | | Bosutinib | | 28.05.2024 | | |
| | Composition | | bosutinibum 400 mg ut bosutinibum dihydricum, cellulosum microcristallinum, crospovidonum, poloxamerum 188, povidonum K 25, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 6000, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Bosutinibum | 400 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 6000 | | | Magnesii Stearas | | | | Poloxamer | 188 | | | Povidonum K | 25 | | | Pro Compresso Obducto | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 28 | DDP | DDP | A | | Non |
|
|
